CONTEXT: Kidney, prostate, and @entity150 increase with age and are influenced partly by modifiable risk factors. @entity5 rates may increase substantially amid a growing, aging population. OBJECTIVE: To describe kidney, @entity263 incidence, mortality, and risk factor-attributable bladder and @entity703 @entity204 between 1990 and 2013, by age, sex, and development status. EVIDENCE ACQUISITION: @entity5 mortality data were derived from global vital registries. Incidence data from @entity5 registries were transformed to mortality estimates using separately estimated mortality incidence ratios. These sources served as input data for an ensemble modeling approach to estimate bladder, prostate, and @entity703 mortality. Cause-specific mortality estimates were transformed into incidence estimates using mortality incidence ratios. EVIDENCE SYNTHESIS: In 2013, 2.1 million kidney, @entity263 cases occurred worldwide, increasing 2.5-fold since 1990. Mortality increased 1.6-fold between 1990 and 2013. Eight-two percent of new cases in 2013 occurred in individuals aged 60 yr and older. @entity1 from developed countries had the highest age-standardized @entity204 rates among all three @entity5 . Smoking-attributable @entity703 @entity204 decreased while @entity28 -related @entity204 rose, most prominently in @entity1 from developing countries. Smoking-related @entity150 @entity204 increased among @entity1 from developed countries and decreased among @entity1 . CONCLUSIONS: @entity5 burden has increased globally amid population growth and aging. High income countries face the highest incidence and @entity204 rates; however, @entity28 -attributed @entity703 @entity204 are increasing in developing countries. Efforts to expand the global oncologic workforce and reduce preventable factors may lessen @entity5 disparities in developing countries. @entity1 SUMMARY: We describe the impact of population growth, aging, and lifestyle factors such as smoking and @entity28 , on kidney, @entity263 rates worldwide. More new @entity5 cases and @entity204 occur in developed countries compared with developing countries. In addition to preventive efforts, healthcare systems must emphasize training of a urologic oncology workforce.

Global Burden of XXXX , 1990-2013.

@entity1 :: ('9606', 'Species') :: ['men', 'women', 'Men', 'PATIENT'] @entity263 :: ('MESH:D011471', 'Disease') :: ['bladder, and prostate cancer', 'bladder, and prostate cancers'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Cancer', 'cancers', 'cancer', 'Urologic cancer', 'Urological cancer'] @entity150 :: ('MESH:D001749', 'Disease') :: ['bladder cancers', 'bladder cancer'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death', 'deaths'] @entity703 :: ('MESH:D007680', 'Disease') :: ['kidney cancer']
@entity5 :: (MESH:D009369,Disease) :: ['Urologic Cancers']
